Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy

In this study, we characterized five Ullrich scleroatonic muscular dystrophy patients (two Italians, one Belgian, and two Turks) with a clinical phenotype showing different degrees of severity, all carrying mutations localized in COL6A1. We sequenced the three entire COL6 complementary DNA. Three of five patients have recessive mutations: two patients (P1and P3) have homozygous single‐nucleotide deletions, one in exon 9 and one in exon 22; one patient (P2) has a homozygous single‐nucleotide substitution leading to a premature termination codon in exon 31. The nonsense mutation of P2 also causes a partial skipping of exon 31 with the formation of a premature termination codon in exon 32 in 15% of the total COL6A1 messenger RNA. The remaining two patients carry a heterozygous glycine substitution in exons 9 and 10 inside the triple‐helix region; both are dominant mutations because the missense mutations are absent in the DNA of their respective parents. As for the three homozygous recessive mutations, the apparently healthy consanguineous parents all carry a heterozygous mutated allele. Here, for the first time, we report a genotype–phenotype correlation demonstrating that heterozygous glycine substitutions in the triple‐helix domain of COL6A1 are dominant and responsible for a milder Ullrich scleroatonic muscular dystrophy phenotype, and that recessive mutations in COL6A1 correlate with more severe clinical and biochemical Ullrich scleroatonic muscular dystrophy phenotypes. Ann Neurol 2005;58:400–410

[1]  K. Bushby,et al.  Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy , 2005, Journal of Medical Genetics.

[2]  K. North,et al.  Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. , 2004, Human molecular genetics.

[3]  B. Echenne,et al.  Collagen VI Status and Clinical Severity in Ullrich Congenital Muscular Dystrophy: Phenotype Analysis of 11 Families Linked to the COL6 Loci , 2004, Neuropediatrics.

[4]  Y Suzuki,et al.  Ullrich disease due to deficiency of collagen VI in the sarcolemma , 2004, Neurology.

[5]  J. Aicardi,et al.  Ullrich's congenital atonic sclerotic muscular dystrophy , 1989, Journal of Neurology.

[6]  S. Marie,et al.  New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. , 2003, American journal of human genetics.

[7]  E. Bertini,et al.  Bethlem myopathy (BETHLEM) and Ullrich scleroatonic muscular dystrophy: 100th ENMC International Workshop, 23–24 November 2001, Naarden, The Netherlands , 2002, Neuromuscular Disorders.

[8]  E. Bertini,et al.  Effects on Collagen VI mRNA Stability and Microfibrillar Assembly of Three COL6A2 Mutations in Two Families with Ullrich Congenital Muscular Dystrophy* , 2002, The Journal of Biological Chemistry.

[9]  I. Nonaka,et al.  Ullrich disease: Collagen VI deficiency: EM suggests a new basis for muscular weakness , 2002, Neurology.

[10]  E. Bertini,et al.  Collagen type VI and related disorders: Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. , 2002, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[11]  B. Echenne,et al.  Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy. , 2002, American journal of human genetics.

[12]  Nimish J. Thakore,et al.  Novel mutations in collagen VI genes: Expansion of the Bethlem myopathy phenotype , 2002, Neurology.

[13]  K. Arimura,et al.  Frameshift mutation in the collagen VI gene causes Ullrich's disease , 2001, Annals of neurology.

[14]  E. Bertini,et al.  Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Bertini,et al.  A novel de novo mutation in the triple helix of the COL6A3 gene in a two-generation Italian family affected by Bethlem myopathy. A diagnostic approach in the mutations' screening of type VI collagen , 1999, Neuromuscular Disorders.

[16]  E. Bertini,et al.  A heterozygous splice site mutation in COL6A1 leading to an in-frame deletion of the alpha1(VI) collagen chain in an italian family affected by bethlem myopathy. , 1999, Biochemical and biophysical research communications.

[17]  P. Barth,et al.  UvA-DARE ( Digital Academic Repository ) Collagen VI mutations in Bethlem myopathy , 2012 .

[18]  A. Palotie,et al.  Head to tail organization of the human COL6A1 and COL6A2 genes by fiber-FISH. , 1995, Genomics.

[19]  L. Merlini,et al.  Bethlem myopathy: Early-onset benign autosomal dominant myopathy with contractures. Description of two new families , 1994, Neuromuscular Disorders.

[20]  R. Mecham,et al.  Extracellular matrix assembly and structure , 1994 .

[21]  R. Timpl,et al.  Microfibrillar Collagen Type VI , 1994 .

[22]  R. Timpl,et al.  The Structure of Type VI Collagen a , 1990, Annals of the New York Academy of Sciences.

[23]  M L Chu,et al.  Mosaic structure of globular domains in the human type VI collagen alpha 3 chain: similarity to von Willebrand factor, fibronectin, actin, salivary proteins and aprotinin type protease inhibitors. , 1990, The EMBO journal.

[24]  R. Timpl,et al.  Amino acid sequence of the triple-helical domain of human collagen type VI. , 1988, The Journal of biological chemistry.

[25]  R. Timpl,et al.  Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. , 1988, American journal of human genetics.

[26]  R. Timpl,et al.  Type VI collagen in extracellular, 100-nm periodic filaments and fibrils: identification by immunoelectron microscopy , 1986, The Journal of cell biology.

[27]  R. Glanville,et al.  The Structure of Type IV Collagen a , 1985, Annals of the New York Academy of Sciences.

[28]  R. Timpl,et al.  Electron-microscopical approach to a structural model of intima collagen. , 1983, The Biochemical journal.

[29]  I. Nonaka,et al.  A clinical and histological study of Ullrich's disease (congenital atonic-sclerotic muscular dystrophy). , 1981, Neuropediatrics.

[30]  O. Ullrich Kongenitale, atonisch-sklerotische Muskeldystrophie, ein weiterer Typus der heredodegenerativen Erkrankungen des neuromuskulären Systems , 1930 .